Friday, 28 July 2017

AbbVie's profit rises 19 percent on Humira demand

(Reuters) - U.S. drugmaker AbbVie Inc reported an 18.9 percent rise in quarterly profit on Friday on strong demand for its flagship rheumatoid arthritis drug, Humira.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)